Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06198751
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2023-12-27
Brief Title:
A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 HER2 Positive Breast Cancer
Sponsor:
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd